VU Medicinal Chemists develop Virtual Machine for Computer-Aided Drug Discovery

 

A team of cheminformatics and bioinformatics researchers from Vrije Universiteit Amsterdam, Radboud university medical center Nijmegen, BioAxis Research, and Netherlands eScience Center have developed a freely available virtual machine to enable computer-aided drug design.

The 3D-e-Chem consortium, led by Amsterdam Data Science Researcher Dr. Chris de Graaf (Division Medicinal Chemistry, VU Amsterdam), develops new cheminformatics technologies to improve the integration of chemical and biological data for the prediction of structural interactions between drug molecules and therapeutic protein targets. The computational drug discovery platform is currently applied to identify and optimize molecules that act on several proteins simultaneously (polypharmacology), while avoiding undesired side effects via interactions with off-target proteins.

The 3D-e-Chem software tools and virtual machine are described in a recent publication in the Journal of Chemical Modeling and Information and the computational building blocks (nodes) that enable researchers to design their own drug discovery workflows have been incorporated in KNIME, the leading open data analytics platform.

 

Read More

  • Peter Boncz appointed ACM Fellow

    CWI researcher Peter Boncz has been appointed as one of the 2022 fellows of the Association of Computing Machinery (ACM).

  • Winners of the ADS Thesis Awards 2022

    The ADS Thesis Award winners for 2022 are Philipp Sommerhalter and Sarah Kwakkelaar in the BSc category and Krijn Doekemeijer and Julia Sudnik for the MSc category. The winners were announced at the ADS Highlights Event on the 8th of December 2022!

  • Symposium in honor of Cees de Laat and Leon Gommans

    A symposium entitled ‘From Systems and Networks to Complex Cyber Infrastructures’ took place on 9th December 2022 in honor of Cees de Laat (UvA IvI) and Leon Gommans (UvA IvI).